Company Insights

SOBR customer relationships

SOBR customer relationship map

SOBR Safe: customer map and what it means for investors

SOBR Safe sells wearable alcohol-detection hardware (SOBRsure) and touch-based devices (SOBRcheck) and monetizes through one-time device sales plus recurring monthly billing for enterprise and consumer subscribers. The company distributes through a mix of direct sales and channel partners, with a small but defined base of subscribers and early reseller agreements that drive geographic expansion in North America. For investors, the core thesis is simple: revenue trajectory depends on scaling resellers and converting pilot customers into longer-duration subscribers while operating against short-term contract economics.
Explore more company relationship intelligence at https://nullexposure.com/.

Customer relationships: who is buying SOBR products

SOBR Safe’s public customer mentions are concentrated in partnerships and reseller agreements announced in FY2022 and later press coverage. Below are each of the relationships recorded in public sources and what they mean in plain English.

RubiRides

SOBR Safe will supply RubiRides’ growing pool of drivers with the SOBRsure™ wearable wristband to detect alcohol emitted through the skin, embedding SOBR hardware into a ride-service safety program. This partnership was reported in a Yahoo Finance release in March 2026 (press coverage of the program rollout): https://finance.yahoo.com/news/sobrsafe-partners-rubirides-introduce-higher-130000863.html.

Butterfield Onsite Drug Testing

Third‑party administrator Butterfield purchased SOBRcheck touch‑based detection hardware and launched a new service line using that technology, signaling adoption by occupational and clinical testing channels. The arrangement was documented in a Zacks research note summarizing company announcements from 2022: https://scr.zacks.com/news/news-details/2022/SOBR-Advanced-technology-company-disrupting-the-alcohol-management-industry-by-focusing-on-preventive-solutions-instead-of-reactive-processes/default.aspx.

Continental Services

Continental Services signed to utilize the SOBRcheck device, indicating uptake among service providers that manage workforce testing or safety programs. This usage was mentioned in the same 2022 Zacks summary of SOBR Safe corporate announcements: https://scr.zacks.com/news/news-details/2022/SOBR-Advanced-technology-company-disrupting-the-alcohol-management-industry-by-focusing-on-preventive-solutions-instead-of-reactive-processes/default.aspx.

North‑Star Care

North‑Star Care, a virtual reality alcohol dependency treatment platform, agreed to use the SOBRcheck wristband as part of its treatment offering, integrating SOBR hardware with digital therapy modalities. This partnership was announced by SOBR and captured by Zacks in 2022: https://scr.zacks.com/news/news-details/2022/SOBR-Advanced-technology-company-disrupting-the-alcohol-management-industry-by-focusing-on-preventive-solutions-instead-of-reactive-processes/default.aspx.

Reconnect

SOBR signed a distribution agreement with value‑added reseller Reconnect to broaden channels into new customer segments and geographies; this is a classic reseller move to expand reach without direct sales overhead. The agreement was disclosed in SOBR’s 2022 announcements and summarized by Zacks: https://scr.zacks.com/news/news-details/2022/SOBR-Advanced-technology-company-disrupting-the-alcohol-management-industry-by-focusing-on-preventive-solutions-instead-of-reactive-processes/default.aspx.

RecoveryTrek

RecoveryTrek entered a reseller agreement to expand SOBR Safe’s national footprint, positioning the company to leverage RecoveryTrek’s client base for broader distribution of hardware and services. This reseller arrangement was detailed in the company’s 2022 disclosures and reported by Zacks: https://scr.zacks.com/news/news-details/2022/SOBR-Advanced-technology-company-disrupting-the-alcohol-management-industry-by-focusing-on-preventive-solutions-instead-of-reactive-processes/default.aspx.

What the partnership set reveals about SOBR’s operating model

The collection of customers and resellers forms a coherent, early-stage commercial strategy. Several company-level signals stand out from public filings and disclosures:

  • Short-term, monthly billing posture. The company states contracts are generally three to twelve months in duration, billed monthly and non-cancelable, which creates predictable but short-lived revenue commitments and requires constant renewal activity to sustain ARR (company filings describing contract terms).
  • Subscription foundation with limited scale. As of December 31, 2024, SOBR reported 127 active B2C subscribers (average monthly length 5.3 months) and 20 active enterprise subscribers covering 1,534 users, indicating a subscription revenue base exists but remains small and early-stage (company filing data, Dec 31, 2024).
  • North America focus. Management positions its principal markets in North America, concentrating go-to-market execution in a single region (company disclosure).
  • Seller posture via channels and direct sales. SOBR distributes through a mix of direct sales and channel partners, reflecting a go-to-market model that relies on resellers for scale rather than a large internal enterprise salesforce (company statements).
  • Hybrid hardware + software business. The company describes itself as a hardware and software business: device sales (SOBRsure, SOBRcheck) plus recurring software/subscription billing (corporate description).

These signals collectively create a company profile of early commercial maturity, low revenue scale, and a channel-driven growth strategy requiring execution against customer acquisition, retention, and reseller enablement.

Explore relationship intelligence and benchmarks for your portfolio at https://nullexposure.com/.

Financial and strategic implications for investors

SOBR’s financials and customer map define clear upside and identifiable risks:

  • Upside: Reseller agreements with Reconnect and RecoveryTrek, and sector applications through Butterfield and Continental, create multiple go-to-market paths that can accelerate device distribution and subscription onboarding if channel economics scale.
  • Key risks: Short contract durations and the small subscriber base require high conversion and renewal rates to create meaningful recurring revenue; the latest trailing twelve‑month revenue is $364,160 while EBITDA is deeply negative (company financials through the 2025-09-30 quarter), underscoring capital intensity and execution risk. Device adoption must translate into subscription retention to change the revenue mix materially.
  • Concentration and criticality: Current public relationships are primarily reseller and pilot deployments, not multi-year enterprise mandates, so revenue criticality is low per customer but high in aggregate if resellers fail to perform.

How to act as an investor evaluating SOBR

For analysts and investors, focus diligence on three operational checkpoints:

  • Monitor subscription growth and average subscription length beyond the Dec‑2024 baseline of 5.3 months for B2C and the 1,534 enterprise-user count.
  • Track channel partner KPIs—reseller order flow, churn, and conversion rates from pilots to paid deployments—because SOBR’s go-to-market depends on these partners.
  • Watch cash flow and margin trends as device volume scales; with current negative EBITDA, capital efficiency during scaling is a primary valuation lever.

For additional relationship intelligence and ongoing monitoring, visit https://nullexposure.com/ for deeper coverage.

Bottom line

SOBR Safe has built an early commercial footprint by selling wearable and touch-based alcohol-detection hardware through a mix of direct and reseller channels and backing device sales with monthly-billed subscriptions. The company’s path to durable revenue runs through resellers and recurring subscriber retention, and current public partnerships validate product-market fit in safety and treatment verticals while leaving execution and scaling as the central investment hypothesis.